Skip to main content
logo
Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
6.83
+0.02 (0.29%)
Oct 31, 2025, 4:00 PM EDT - Market closed

Champions Oncology Revenue

Champions Oncology had revenue of $14.00M in the quarter ending July 31, 2025, a decrease of -0.47%. This brings the company's revenue in the last twelve months to $56.88M, up 10.11% year-over-year. In the fiscal year ending April 30, 2025, Champions Oncology had annual revenue of $56.94M with 13.54% growth.

Revenue (ttm)
$56.88M
Revenue Growth
+10.11%
P/S Ratio
1.65
Revenue / Employee
$267,033
Employees
213
Market Cap
94.31M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Apr 30, 202556.94M6.79M13.54%
Apr 30, 202450.16M-3.72M-6.90%
Apr 30, 202353.87M4.76M9.69%
Apr 30, 202249.11M8.07M19.66%
Apr 30, 202141.04M8.92M27.76%
Apr 30, 2020 Pro Pro Pro
Apr 30, 2019 Pro Pro Pro
Apr 30, 2018 Pro Pro Pro
Apr 30, 2017 Pro Pro Pro
Apr 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG56.37B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

CSBR News

More News